Tau hyperphosphorylation and conformational changes in the brain parenchyma start around seven months. Tangle-like pathology is mainly observed in the brain stem and spinal cord, and to a lesser ...

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...

Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...

Copyright 2025 The Associated Press. All Rights Reserved. Tau is an investigative reporter in the Washington, D.C. bureau of the Associated Press. He focuses on ...

After hours: February 12 at 6:10:39 PM EST Loading Chart for DRTS ...